| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.004 | 1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |